Evidence map›Paper›PMID 22969053›Full record

ArticleAngewandte Chemie (International ed. in English)2012

Discovery of small-molecule inhibitors of the TLR1/TLR2 complex.

Kui Cheng, Xiaohui Wang, Shuting Zhang, Hang Yin

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Targeted lungScience advances · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kui ChengDepartment of Chemistry and Biochemistry and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309, USA.
Xiaohui Wang
Shuting Zhang
Hang Yin

Funding

Exogenous Chemical Probes of TLR-Mediated NeuroinflammationR01GM101279 · NIGMS · UNIVERSITY OF COLORADO · PI YIN, HANG HUBERT · 2013 to 2017
$1.4M
Developing Small-Molecule Probes for Opioid-Induced Glial ActivationR21NS067425 · NINDS · UNIVERSITY OF COLORADO · PI YIN, HANG HUBERT · 2009 to 2010
$452k
Transforming Clinical Pain Control by Targeting a Novel Non-Neuronal ReceptorR03DA025740 · NIDA · UNIVERSITY OF COLORADO · PI YIN, HANG HUBERT · 2009 to 2010
$379k
Optimizing the Clinical Efficacy of Opioids by TLR4 BlockadeR21DA026950 · NIDA · UNIVERSITY OF COLORADO · PI YIN, HANG HUBERT · 2009 to 2010
$273k
NIDA NIH HHS DA025740NIDA NIH HHS DA026950NIDA NIH HHS R03 DA025740NIDA NIH HHS R21 DA026950NIGMS NIH HHS R01 GM101279NINDS NIH HHS NS067425NINDS NIH HHS R21 NS067425
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBiflavonoidsCatechinDrug DiscoveryMacrophagesMiceNitric OxideStructure-Activity RelationshipToll-Like Receptor 1Toll-Like Receptor 2benzotropoloneBiflavonoidsCatechinNitric OxideToll-Like Receptor 1Toll-Like Receptor 2

Identifiers

PMID22969053
PMCPMC3510333

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.